Evaporate Study! Vascepa is Liquid Stent! Wow!







Its positive news, but not a game changer. It helps further confirm MOA. Statins have been shown to reduce LAP by 24%, so this falls just shy of that. Long story short, the story remains the same. Certain lipid lowering drugs like statins and vascepa have an effect on plaque regression and CV outcomes. Added on to a statin, there is a known benefit. You'll see the stock price barely move because of this information. However, if the appeal is won, bye bye generics.
 


















Geez, who made a great point except for the generic part....I predict the generics will go away for awhile, so should you!

Jokes on you, Woody! Appeal is lost. I do applaud your company pride/spirit though. Hey, what's the average possibility of an En Banc Review going our way? Like 0.57%? Meh. Good luck and May the odds be ever in your favor!